Skip to main content
. 2025 Feb 11;47(2):119. doi: 10.3390/cimb47020119

Figure 1.

Figure 1

Schematic overview of the therapeutic approaches for causal treatment of CF. Investigational and currently available drugs for the treatment of CF have been developed to target the basic defect in CFTR. They act at various points in the CFTR biogenesis and maturation pathway. The beneficial effect of these molecules can be enhanced when administrated in combination, as the combination addresses different defects of the CFRT protein.